These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 31256129)

  • 21. Anticoagulant Initiation During Hospital Admissions for Atrial Fibrillation in South-East Queensland, Australia.
    Rathinam I; Anoopkumar-Dukie S; Badrick T; Teasdale T; Bernaitis N
    Heart Lung Circ; 2020 Sep; 29(9):e222-e230. PubMed ID: 32291155
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinician Trends in Prescribing Direct Oral Anticoagulants for US Medicare Beneficiaries.
    Wheelock KM; Ross JS; Murugiah K; Lin Z; Krumholz HM; Khera R
    JAMA Netw Open; 2021 Dec; 4(12):e2137288. PubMed ID: 34870678
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Rivaroxaban Versus Warfarin for Stroke Prevention and Venous Thromboembolism Treatment in Extreme Obesity and High Body Weight.
    Perales IJ; San Agustin K; DeAngelo J; Campbell AM
    Ann Pharmacother; 2020 Apr; 54(4):344-350. PubMed ID: 31672028
    [No Abstract]   [Full Text] [Related]  

  • 24. Anticoagulant Prescribing for Non-Valvular Atrial Fibrillation in the Veterans Health Administration.
    Rose AJ; Goldberg R; McManus DD; Kapoor A; Wang V; Liu W; Yu H
    J Am Heart Assoc; 2019 Sep; 8(17):e012646. PubMed ID: 31441364
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Oral anticoagulant use and clinical outcomes in elderly Japanese patients: findings from the SAKURA AF Registry.
    Nishida T; Okumura Y; Yokoyama K; Matsumoto N; Tachibana E; Kuronuma K; Oiwa K; Matsumoto M; Kojima T; Hanada S; Nomoto K; Sonoda K; Arima K; Kogawa R; Takahashi F; Kotani T; Ohkubo K; Fukushima S; Itou S; Kondo K; Chiku M; Ohno Y; Onikura M; Hirayama A;
    Heart Vessels; 2019 Dec; 34(12):2021-2030. PubMed ID: 31183513
    [TBL] [Abstract][Full Text] [Related]  

  • 26. OpenSAFELY: impact of national guidance on switching anticoagulant therapy during COVID-19 pandemic.
    ; Curtis HJ; MacKenna B; Walker AJ; Croker R; Mehrkar A; Morton C; Bacon S; Hickman G; Inglesby P; Bates C; Evans D; Ward T; Cockburn J; Davy S; Bhaskaran K; Schultze A; Rentsch CT; Williamson E; Hulme W; Tomlinson L; Mathur R; Drysdale H; Eggo RM; Wong AY; Forbes H; Parry J; Hester F; Harper S; Douglas I; Smeeth L; Goldacre B
    Open Heart; 2021 Nov; 8(2):. PubMed ID: 34785588
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Direct oral anticoagulants in real clinical practice: analysis of patient characteristics and prescribing patterns in a large teaching hospital.
    Kováčová B; Červeňová J
    Pharmazie; 2017 Sep; 72(9):555-560. PubMed ID: 29441984
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Sex-Based Differences in Outcomes of Oral Anticoagulation in Patients With Atrial Fibrillation.
    Law SWY; Lau WCY; Wong ICK; Lip GYH; Mok MT; Siu CW; Chan EW
    J Am Coll Cardiol; 2018 Jul; 72(3):271-282. PubMed ID: 30012320
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Trends in initiation of direct oral anticoagulant therapies for atrial fibrillation in a national population-based cross-sectional study in the French health insurance databases.
    Huiart L; Ferdynus C; Renoux C; Beaugrand A; Lafarge S; Bruneau L; Suissa S; Maillard O; Ranouil X
    BMJ Open; 2018 Mar; 8(3):e018180. PubMed ID: 29602837
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effectiveness and Safety of Apixaban, Dabigatran, and Rivaroxaban Versus Warfarin in Frail Patients With Nonvalvular Atrial Fibrillation.
    Martinez BK; Sood NA; Bunz TJ; Coleman CI
    J Am Heart Assoc; 2018 Apr; 7(8):. PubMed ID: 29654196
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Anticoagulation trends in adults aged 65 years and over with atrial fibrillation: a cohort study.
    Lund J; Saunders CL; Edwards D; Mant J
    Open Heart; 2021 Aug; 8(2):. PubMed ID: 34344724
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of Oral Anticoagulants on Patients With Atrial Fibrillation Aged 90 Years and Older: Comparison Among Direct Oral Anticoagulant, Warfarin Anticoagulant, and Nonanticoagulation.
    Yamaji H; Higashiya S; Murakami T; Hina K; Kawamura H; Murakami M; Kamikawa S; Hirohata S; Kusachi S
    J Cardiovasc Pharmacol; 2019 Sep; 74(3):246-254. PubMed ID: 31498193
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prescribers' views and experiences of using direct acting oral anticoagulants in the management of nonvalvular atrial fibrillation: A survey in remote and rural Scotland.
    Generalova D; Cunningham S; Leslie SJ; Rushworth G; McIver L; Stewart D
    Br J Clin Pharmacol; 2019 Oct; 85(10):2414-2422. PubMed ID: 31313317
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Changes in Oral Anticoagulant Treatment Rates in Atrial Fibrillation before and after the Introduction of Direct Oral Anticoagulants.
    Shah RU; Rupp AB; Mowery D; Zhang M; Stoddard G; Deshmukh V; Bray BE; Hess R; Rondina MT
    Neuroepidemiology; 2016; 47(3-4):201-209. PubMed ID: 28135707
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparing the Efficacy and Safety of Direct Oral Anticoagulants With Warfarin in the Morbidly Obese Population With Atrial Fibrillation.
    Kido K; Ngorsuraches S
    Ann Pharmacother; 2019 Feb; 53(2):165-170. PubMed ID: 30130979
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A review of indications and comorbidities in which warfarin may be the preferred oral anticoagulant.
    Wadsworth D; Sullivan E; Jacky T; Sprague T; Feinman H; Kim J
    J Clin Pharm Ther; 2021 Jun; 46(3):560-570. PubMed ID: 33393699
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Disparities and Temporal Trends in the Use of Anticoagulation in Patients With Ischemic Stroke and Atrial Fibrillation.
    Sur NB; Wang K; Di Tullio MR; Gutierrez CM; Dong C; Koch S; Gardener H; García-Rivera EJ; Zevallos JC; Burgin WS; Rose DZ; Goldberger JJ; Romano JG; Sacco RL; Rundek T
    Stroke; 2019 Jun; 50(6):1452-1459. PubMed ID: 31084325
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Association of Depression and Adherence to Oral Anticoagulation in Patients With Atrial Fibrillation.
    Lapa ME; Swabe GM; Magnani JW
    J Am Heart Assoc; 2023 Nov; 12(22):e031281. PubMed ID: 37982265
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evaluation of Direct Oral Anticoagulants Versus Warfarin for Intracardiac Thromboses.
    Iskaros O; Marsh K; Papadopoulos J; Manmadhan A; Ahuja T
    J Cardiovasc Pharmacol; 2021 May; 77(5):621-631. PubMed ID: 33560043
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Predictors of Direct Oral Anticoagulants Utilization for Thromboembolism Prevention in Atrial Fibrillation.
    Brais C; Larochelle J; Turgeon MH; Blais L; Farand P; Perreault S; Letemplier G; Beauchesne MF
    J Pharm Pharm Sci; 2017; 20():8-14. PubMed ID: 28459661
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.